Toxicity screening using biosensors that measure DNA damage

Current Opinion in Drug Discovery and Development

Volumn 10, Issue 1, 2007, Pages 67-73

  Rusling, James F ^a,b   Hvastkovs, Eli G ^a   Schenkman, John B ^b  

^a UNIVERSITY OF CONNECTICUT   (United States)

^b UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

Biomarker; Biosensor; Cytochrome P450; DNA; Toxicity

Indexed keywords

BIOLOGICAL MARKER; CYTOCHROME P450;

BIOSENSOR; CHEMOLUMINESCENCE; CONFERENCE PAPER; DNA DAMAGE; DNA MICROARRAY; ELECTROCHEMISTRY; GENOTOXICITY; HUMAN; METHODOLOGY; NONHUMAN; OXIDATIVE STRESS; POTENTIOMETRY; TOXICITY TESTING;

ANIMALS; BIOSENSING TECHNIQUES; DNA DAMAGE; HUMANS; MUTAGENICITY TESTS; REPRODUCIBILITY OF RESULTS;

EID: 33947325325     PISSN: 13676733     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (46)

1. Nassar AE, Kamel AM, Clarimont C: Improving the decision-making process in structural modification of drug candidates: Reducing toxicity. Drug Discov Today (2004) 9(24):1055-1064.
2. Caldwell GW, Yan Z: Screening for reactive intermediates and toxicity assessment in drug discovery. Curr Opin Drug Discovery Dev (2006) 9(1):47-60.
3. Mayne JT, Ku WW, Kennedy SP: Informed toxicity assessment in drug discovery: Systems-based toxicology. Curr Opin Drug Discovery Dev (2006) 9(1):75-83.
4. Singer B, Grunberger D: Molecular Biology of Mutagens and Carcinogens. Plenum Press, New York, NY, USA (1983).
5. Jacoby W (Ed): Enzymatic Basis of Detoxification. Academic Press, New York, NY, USA (1980).
6. Friedberg EC: DNA damage and repair. Nature (2003) 421(6921):436-440.
7. Scharer OD: Chemistry and biology of DNA repair. Angew Chem Int Ed Engl (2003) 42(26):2946-2974.
8. Bond JA: Review of the toxicology of styrene. Crit Rev Toxicol (1989) 19(3):227-249.
9. Pauwels W, Vodiceka P, Severi M, Plna K, Veulemans H, Hemminki K: Adduct formation on DNA and haemoglobin in mice intraperitoneally administered with styrene. Carcinogenesis (1996) 17(12):2673- 2680.
10. Wang M, McIntee EJ, Shi Y, Cheng G, Upadhyaya P, Villalta PW, Hecht SS: Reactions of α-acetoxy-N-nitrosopyrrolidine with deoxyguanosine and DNA. Chem Res Toxicol (2001) 14(10):1435- 1445.
11. Cavalieri EL, Rogan EG, Devanesan PD, Cremonesi P, Cerny RL, Gross ML, Bodell WJ: Binding of benzo[a]pyrene to DNA by cytochrome P-450 catalyzed one-electron oxidation in rat liver microsomes and nuclei. Biochemistry (1990) 29(20):4820-4827.
12. Phillips DH, Farmer PB, Beland FA, Nath RG, Poirier MC, Reddy MV, Turteltaub KW: Methods of DNA adduct determination and their application to testing compounds for genotoxicity. Environ Mol Mutagen (2000) 35(3):222-233.
13. Warren AJ, Shields PG: Molecular epidemiology: Carcinogen-DNA adducts and genetic susceptibility. Proc Soc Exp Biol Med (1997) 216(2):172-180.
14. Rusling J: Sensors for genotoxicity and oxidized DNA. In: Electrochemistry of Nucleic Acids and Proteins. Palecek E, Scheller F, Wang J (Eds), Elsevier Science, Amsterdam, the Netherlands (2005):433-450. •• A recent review of biosensors detecting genotoxicity screening and oxidized DNA.
15. Rusling JF: Sensors for toxicity of chemicals and oxidative stress based on electrochemical catalytic DNA oxidation. Biosens Bioelectron (2004) 20(5):1022-1028. •• A review of earlier development of biosensors detecting genotoxicity screening and oxidized DNA.
16. Zhou L, Yang J, Estavillo C, Stuart JD, Schenkman JB, Rusling JF: Toxicity screening by electrochemical detection of DNA damage by metabolites generated in situ in ultrathin DNA-enzyme films. J Am Chem Soc (2003) 125(5):1431-1436.
17. Dennany L, Forster RJ, Rusling JF: Simultaneous direct electrochemiluminescence and catalytic voltammetry detection of DNA in ultrathin films. J Am Chem Soc (2003) 125(17):5213-5218.
18. Tarun M, Bajrami B, Rusling JF: Genotoxicity screening using biocatalyst/DNA films and capillary LC-MS/MS. Anal Chem (2006) 78(2):624-627.
19. Tarun M, Rusling JF: Measuring DNA nucleobase adducts using neutral hydrolysis and liquid chromatography-mass spectrometry. Crit Rev Eukaryot Gene Expr (2005) 15(4):295-316.
20. Lvov Y: Thin-film nanofabrication by alternate adsorption of polyions, nanoparticles, and proteins. In: Handbook of Surfaces and Interfaces of Materials, Volume 3. Nanostructured Materials, Micelles and Colloids. Nalwa R (Ed), Academic Press, San Diego, CA (2001):170-189.
21. 2+. Anal Chem (2001) 73(20):4780-4786.
22. + as catalyst in ultrathin films. DNA damage from methylating agents and an enzyme-generated epoxide. Anal Chem (2003) 75(16):4229-4235.
23. Tarun M, Rusling JF: Quantitative measurement of DNA adducts using neutral hydrolysis and LC-MS. Validation of genotoxicity sensors. Anal Chem (2005) 77(7):2056-2062. •• A review of LC-MS methods for determining DNA adducts including the use of DNA/enzyme films.
24. Yang J, Wang B, Rusling JF: Genotoxicity sensor response correlated with DNA nucleobase damage rates measured by LC-MS. Mol Biosyst (2005) 1(3):251-259.
25. Gonzalez FJ: Human cytochromes P450: Problems and prospects. Trends Pharmacol Sci (1992) 13(9):346-352.
26. Guengerich FP: Polymorphism of cytochrome P-450 in humans. Trends Pharmacol Sci (1989) 10(3):107-109.
27. Wang B, Jansson I, Schenkman JB, Rusling JF: Evaluating enzymes that generate genotoxic benzo[a]pyrene metabolites using sensor arrays. Anal Chem (2005) 77(5):1361-1367. • First paper describing CYP/DNA genotoxicity arrays.
28. Hvastkovs EG, So M, Krishnan S, Bajrami B, Tarun M, Jansson I, Schenkman JB, Rusling JF: Electrochemiluminescent arrays for cytochrome P450-activated genotoxicity screening. DNA damage from benzo[a]pyrene metabolites. Anal Chem (2006): in press. • First paper describing CYP/DNA genotoxicity arrays with electrochemiluminescent detection
29. Viravaidya K, Sin A, Shuler ML: Development of a microscale cell culture analog to probe naphthalene toxicity. Biotechnol Prog (2004) 20(1):316-323.
30. 50 values that were studied by several methods for 612 compounds with various degrees of hepatotoxicity (ranging from severe to negligible). The predictive nature of the detection platform is discussed.
31. Vansant G, Pezzoli P, Saiz R, Birch A, Duffy C, Ferre F, Monforte J: Gene expression analysis of troglitazone reveals its impact on multiple pathways in cell culture: A case for in vitro platforms combined with gene expression analysis for early (idiosyncratic) toxicity screening. Int J Toxicol (2006) 25(2):85-94.
32. Li AP, Bode C, Sakai Y: A novel in vitro system, the integrated discrete multiple organ cell culture (IDMOC) system, for the evaluation of human drug toxicity: Comparative cytotoxicity of tamoxifen towards normal human cells from five major organs and MCF-7 adenocarcinoma breast cancer cells. Chem Biol Interact (2004) 150(1):129-136. • Study that shows tamoxifen is more toxic to breast cancer cells compared to healthy organ cells, as measured by ATP generation.
33. Zhang X, Wang W, Yu W, Xie Y, Zhang X, Zhang Y, Ma X: Development of an in vitro multicellular tumor spheroid model using microencapsulation and its application in anticancer drug screening and testing. Biotechnol Prog (2005) 21(4):1289-1296. • Spheroid encapsulated cells are more resistant to selected chemotherapeutic drugs compared to monolayer cell culture because the former is more effective in modeling in vivo tumor tissue, thereby providing a more accurate view of drug toxicity to cells.
34. Cui HF, Ye JS, Chen Y, Chong SC, Sheu FS: Microelectrode array biochip: Tool for in vitro drug screening based on the detection of a drug effect on dopamine release from PC12 cells. Anal Chem (2006) 78(18):6347-6355.
35. Natarajan A, Molnar P, Sieverdes K, Jamshidi A, Hickman JJ: Microelectrode array recordings of cardiac action potentials as a high throughput method to evaluate pesticide toxicity. Toxicol In Vitro (2006) 20(3):375-381.
36. Lee MY, Park CB, Dordick JS, Clark DS: Metabolizing enzyme toxicology assay chip (metachip) for high-throughput microscale toxicity analyses. Proc Natl Acad Sci USA (2005) 102(4):983-987. •• CYPs retain stability in sol-gel mixtures, hence this mixture enables the study of multiple isoforms of CYPs; 30-nl sample volumes of drugs were exposed to each CYP location.
37. Vignati L, Turlizzi E, Monaci S, Grossi P, Kanter R, Monshouwer M: An in vitro approach to detect metabolite toxicity due to CYP3A4-dependent bioactivation of xenobiotics. Toxicology (2005) 216(2-3):154-167.
38. Gao J, Ann Garulacan L, Storm SM, Hefta SA, Opiteck GJ, Lin JH, Moulin F, Dambach DM: Identification of in vitro protein biomarkers of idiosyncratic liver toxicity. Toxicol In Vitro (2004) 18(4):533-541. • BMS-PTX-265 and BMS-PTX-837 are identified as biomarkers that evolve from cultured cells exposed to toxic media versus non-toxic media.
39. Kuang Y, Biran I, Walt DR: Living bacterial cell array for genotoxin monitoring. Anal Chem (2004) 76(10):2902-2909. • Describes a high-density fiber optic array that can be tailored to theoretically fit any cell size and be used as a high-throughput toxicity screening device.
40. Mitchell RJ, Gu MB: An Escherichia coli biosensor capable of detecting both genotoxic and oxidative damage. Appl Microbiol Biotechnol (2004) 64(1):46-52.
41. Mitchell RJ, Gu MB: Construction and characterization of novel dual stress-responsive bacterial biosensors. Biosens Bioelectron (2004) 19(9):977-985.
42. Lee JH, Mitchell RJ, Kim BC, Cullen DC, Gu MB: A cell array biosensor for environmental toxicity analysis. Biosens Bioelectron (2005) 21(3):500-507.
43. Shigenaga MK, Ames BN: Assays for 8-hydroxy-2′-deoxyguanosine: A biomarker of in vivo oxidative DNA damage. Free Radic Biol Med (1991) 10(3-4):211-216.
44. Mugweru A, Wang B, Rusling J: Voltammetric sensor for oxidized DNA using ultrathin films of osmium and ruthenium metallopolymers. Anal Chem (2004) 76(18):5557-5563.
45. White B, Smyth MR, Stuart JD, Rusling JF: Oscillating formation of 8-oxoguanine during DNA oxidation. J Am Chem Soc (2003) 125(22):6604-6605.
46. 2+. J Am Chem Soc (2004) 126(28):8835-8841.